Cost-Effectiveness Analysis and the Formulary Decision-Making Process

BACKGROUND: Faced with high drug expenditures in an environment of cost containment, drug formulary systems, particularly in managed care, have become more dependent on pharmacoeconomic evaluations to assess the value of new products. Within pharmacoeconomics (PE), cost-effectiveness analysis (CEA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhixiao, Salmon, J. Warren, Walton, Surrey M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2004
Materias:
Formulary Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437526/
https://www.ncbi.nlm.nih.gov/pubmed/14720105
http://dx.doi.org/10.18553/jmcp.2004.10.1.48

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437526/
https://www.ncbi.nlm.nih.gov/pubmed/14720105
http://dx.doi.org/10.18553/jmcp.2004.10.1.48

Ejemplares similares